Literature DB >> 50100

Imbalances of IgG subclasses and gene defects in patients with primary hypogammaglobulinemia.

W J Yount.   

Abstract

The chance mating of persons with structural or regulator gene abnormalities might be expected to result in individuals who lack the capacity to synthesize specific types of heavy chains and manifest as hypogammaglobulinemia. Disproportionate levels of IgG subclasses would then be expected since the heavy chains are synthesized at separate although closely linked loci. Several instances of such alterations in subclass concentrations have been found. One family has been encountered with probable structural gene abnormalities in the autosomal Gm loci. In addition to their genetic implications, IgG-subclass imbalances are of importance because of the variable distribution of biologic properties of immunoglobulins among the IgG subclasses, and because of the observation that certain antibody populations may be markedly restricted or limited to a single IgG subclass.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50100

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  5 in total

1.  Autoimmunity in the relatives of patients with immunodeficiency diseases.

Authors:  J M Friedman; P J Fialkow; S D Davis; H D Ochs; R J Wedgwood
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

Review 2.  Immunoglobulins in epilepsy.

Authors:  J A Aarli
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Diagnosis of defects of antibody production.

Authors:  A M Ward
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

4.  Nonreaginic anaphylactic and/or blocking antibodies: conclusion.

Authors:  G M Halpern
Journal:  Clin Rev Allergy       Date:  1983-06

5.  Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy.

Authors:  A Fontana; H Joller; F Skvaril; P Grob
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.